Phase II, III trials of Covaxin on volunteers aged 2-18 years, challenged : Delhi HC

The Phase II & III clinical trials of Covid-19 vaccine, Covaxin, which has been approved by the Drugs Controller General of India (DCGI), for in the age group of 2 to 18 years, will begin in the coming 10 to 12 days, Dr VK Paul, Member, NITI Aayog said.

“I have been told that trials will begin in the next 10-12 days,” Dr VK Paul said on Tuesday during a press briefing on Covid-19.

The Bench of Chief Justice DN Patel and Justice Jyoti Singh, however, refused to stay the trials.Since, It is contended that such trials will adversely affect the physical and mental health of such children, and may even result in the loss of their lives.

Therefore, such an order is prima facie unlawful, arbitrary and contrary to the principles of natural justice, the petitioner claims.

Further, it is claimed that given the socio-economic scenario of the country, the possibility of parental consent being obtained through questionable enticements and monetary considerations cannot be ruled out.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s